Alignment Healthcare (NASDAQ:ALHC – Get Free Report) and Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.
Earnings & Valuation
This table compares Alignment Healthcare and Intelligent Bio Solutions”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alignment Healthcare | $3.95 billion | 1.11 | -$720,000.00 | $0.09 | 236.56 |
| Intelligent Bio Solutions | $3.05 million | 1.86 | -$10.57 million | ($12.22) | -0.19 |
Profitability
This table compares Alignment Healthcare and Intelligent Bio Solutions’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alignment Healthcare | 0.47% | 11.50% | 1.79% |
| Intelligent Bio Solutions | -296.73% | -176.09% | -89.71% |
Volatility & Risk
Alignment Healthcare has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.21, indicating that its stock price is 321% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent recommendations and price targets for Alignment Healthcare and Intelligent Bio Solutions, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alignment Healthcare | 0 | 3 | 6 | 1 | 2.80 |
| Intelligent Bio Solutions | 1 | 0 | 0 | 0 | 1.00 |
Alignment Healthcare presently has a consensus price target of $24.30, indicating a potential upside of 14.14%. Given Alignment Healthcare’s stronger consensus rating and higher possible upside, equities analysts clearly believe Alignment Healthcare is more favorable than Intelligent Bio Solutions.
Institutional and Insider Ownership
86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Alignment Healthcare beats Intelligent Bio Solutions on 13 of the 15 factors compared between the two stocks.
About Alignment Healthcare
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
About Intelligent Bio Solutions
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
